IP Group Reports £43m Loss in H1 2025 Amid Challenging Market Conditions
The venture capital firm reported a £43m loss for H1 2025, showing some improvement but facing ongoing challenges in a difficult market environment for early-stage investments.
The venture capital firm reported a £43m loss for H1 2025, showing some improvement but facing ongoing challenges in a difficult market environment for early-stage investments.
The asset manager has announced a change in its major shareholding, with the Railways Pension Trustee Company Limited increasing its stake in the company.
The investment firm announces it will publish its half-year results and host an investor presentation next month.
The biotechnology company announces ground-breaking data from its portfolio company Istesso, showing the potential of its investigational medicines to elicit tissue repair in various chronic conditions.
The investment firm provides an update on its share buyback program, extending the program by £20 million.
The asset manager has disclosed a change in its shareholding position in the company.
The technology company has secured $15m in funding to accelerate the development and deployment of its 5G satellite communications products, with support from IP Group and other investors.
The asset management firm has disclosed a change in major shareholdings.
The healthcare technology company has priced its IPO at the top end of the range, providing a significant return for its early investor IP Group.
The investment firm is hosting a capital markets event for investors and analysts, providing an opportunity to learn more about the company's strategy and portfolio.